In this video, Jeremy Faust, MD, editor-in-chief of MedPage Today, looks at the rise and fall of monoclonal antibodies for COVID-19, and discusses the population most affected by the FDA's reversal of ...
A systematic review reports that monoclonal antibodies and JAK inhibitors can be effective in the treatment and clearance of ...
Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or ...
On 7 August 1975, Nature published a paper that has had some of the greatest impacts on science and health care in modern times. The study, by biochemists Georges Köhler and César Milstein, described ...
Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists. Monoclonal ...
"Without it, I don't know how much worse I would have been," one patient said. Susan Eisen assumed her sore throat and headache would go away. Maybe she'd been working too hard, or not drinking enough ...
Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or ...
Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...
Late-breaking oral presentation will highlight new data from a trial of INCA033989, an anti-mutant calreticulin (mutCALR)-directed monoclonal antibody, in patients with essential thrombocythemia (ET) ...